nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—ESR1—atherosclerosis	0.754	1	CbGaD
Fluoxymesterone—SHBG—hindlimb—atherosclerosis	0.00804	0.193	CbGeAlD
Fluoxymesterone—AR—penis—atherosclerosis	0.00764	0.183	CbGeAlD
Fluoxymesterone—PRLR—liver—atherosclerosis	0.0049	0.118	CbGeAlD
Fluoxymesterone—ESR1—blood vessel—atherosclerosis	0.0027	0.0649	CbGeAlD
Fluoxymesterone—Jaundice cholestatic—Lovastatin—atherosclerosis	0.00252	0.0575	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Simvastatin—atherosclerosis	0.00235	0.0537	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00233	0.0533	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Niacin—atherosclerosis	0.00216	0.0493	CcSEcCtD
Fluoxymesterone—Jaundice cholestatic—Pravastatin—atherosclerosis	0.00213	0.0486	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Lovastatin—atherosclerosis	0.00198	0.0452	CcSEcCtD
Fluoxymesterone—SHBG—connective tissue—atherosclerosis	0.00197	0.0472	CbGeAlD
Fluoxymesterone—Gynaecomastia—Simvastatin—atherosclerosis	0.00185	0.0422	CcSEcCtD
Fluoxymesterone—SHBG—cardiovascular system—atherosclerosis	0.00171	0.0411	CbGeAlD
Fluoxymesterone—Gynaecomastia—Pravastatin—atherosclerosis	0.00167	0.0382	CcSEcCtD
Fluoxymesterone—SHBG—adipose tissue—atherosclerosis	0.00151	0.0362	CbGeAlD
Fluoxymesterone—AR—connective tissue—atherosclerosis	0.00141	0.0339	CbGeAlD
Fluoxymesterone—ESR1—connective tissue—atherosclerosis	0.00139	0.0333	CbGeAlD
Fluoxymesterone—Betamethasone—PLA2G1B—atherosclerosis	0.00137	0.244	CrCbGaD
Fluoxymesterone—Disturbance in sexual arousal—Niacin—atherosclerosis	0.00137	0.0312	CcSEcCtD
Fluoxymesterone—AR—cardiovascular system—atherosclerosis	0.00123	0.0295	CbGeAlD
Fluoxymesterone—ESR1—cardiovascular system—atherosclerosis	0.00121	0.029	CbGeAlD
Fluoxymesterone—Danazol—CCL2—atherosclerosis	0.00112	0.2	CrCbGaD
Fluoxymesterone—AR—adipose tissue—atherosclerosis	0.00108	0.026	CbGeAlD
Fluoxymesterone—ESR1—adipose tissue—atherosclerosis	0.00106	0.0255	CbGeAlD
Fluoxymesterone—SHBG—liver—atherosclerosis	0.00106	0.0254	CbGeAlD
Fluoxymesterone—NR3C1—connective tissue—atherosclerosis	0.00102	0.0246	CbGeAlD
Fluoxymesterone—Alopecia—Lovastatin—atherosclerosis	0.000981	0.0224	CcSEcCtD
Fluoxymesterone—Alopecia—Ezetimibe—atherosclerosis	0.000963	0.022	CcSEcCtD
Fluoxymesterone—Haemoglobin—Niacin—atherosclerosis	0.000959	0.0219	CcSEcCtD
Fluoxymesterone—Haemorrhage—Niacin—atherosclerosis	0.000954	0.0218	CcSEcCtD
Fluoxymesterone—Alopecia—Simvastatin—atherosclerosis	0.000918	0.021	CcSEcCtD
Fluoxymesterone—NR3C1—cardiovascular system—atherosclerosis	0.00089	0.0214	CbGeAlD
Fluoxymesterone—Alopecia—Niacin—atherosclerosis	0.000843	0.0192	CcSEcCtD
Fluoxymesterone—Paraesthesia—Rosuvastatin—atherosclerosis	0.000836	0.0191	CcSEcCtD
Fluoxymesterone—Alopecia—Pravastatin—atherosclerosis	0.00083	0.0189	CcSEcCtD
Fluoxymesterone—Anxiety—Lovastatin—atherosclerosis	0.00082	0.0187	CcSEcCtD
Fluoxymesterone—Dexamethasone—PLA2G1B—atherosclerosis	0.000797	0.142	CrCbGaD
Fluoxymesterone—Anaphylactic shock—Lovastatin—atherosclerosis	0.000789	0.018	CcSEcCtD
Fluoxymesterone—NR3C1—adipose tissue—atherosclerosis	0.000785	0.0188	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000774	0.0177	CcSEcCtD
Fluoxymesterone—Anxiety—Simvastatin—atherosclerosis	0.000767	0.0175	CcSEcCtD
Fluoxymesterone—AR—liver—atherosclerosis	0.00076	0.0182	CbGeAlD
Fluoxymesterone—ESR1—liver—atherosclerosis	0.000746	0.0179	CbGeAlD
Fluoxymesterone—Anaphylactic shock—Simvastatin—atherosclerosis	0.000738	0.0168	CcSEcCtD
Fluoxymesterone—Paraesthesia—Lovastatin—atherosclerosis	0.000708	0.0162	CcSEcCtD
Fluoxymesterone—Paraesthesia—Ezetimibe—atherosclerosis	0.000695	0.0159	CcSEcCtD
Fluoxymesterone—Anxiety—Pravastatin—atherosclerosis	0.000694	0.0158	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000686	0.0157	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Niacin—atherosclerosis	0.000678	0.0155	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Pravastatin—atherosclerosis	0.000667	0.0152	CcSEcCtD
Fluoxymesterone—Paraesthesia—Simvastatin—atherosclerosis	0.000663	0.0151	CcSEcCtD
Fluoxymesterone—Paraesthesia—Niacin—atherosclerosis	0.000608	0.0139	CcSEcCtD
Fluoxymesterone—Paraesthesia—Pravastatin—atherosclerosis	0.000599	0.0137	CcSEcCtD
Fluoxymesterone—Headache—Rosuvastatin—atherosclerosis	0.000583	0.0133	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Lovastatin—atherosclerosis	0.000581	0.0133	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Ezetimibe—atherosclerosis	0.00057	0.013	CcSEcCtD
Fluoxymesterone—Nausea—Rosuvastatin—atherosclerosis	0.000553	0.0126	CcSEcCtD
Fluoxymesterone—NR3C1—liver—atherosclerosis	0.00055	0.0132	CbGeAlD
Fluoxymesterone—Hypersensitivity—Simvastatin—atherosclerosis	0.000544	0.0124	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Niacin—atherosclerosis	0.000499	0.0114	CcSEcCtD
Fluoxymesterone—Headache—Lovastatin—atherosclerosis	0.000494	0.0113	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Pravastatin—atherosclerosis	0.000492	0.0112	CcSEcCtD
Fluoxymesterone—Headache—Ezetimibe—atherosclerosis	0.000485	0.0111	CcSEcCtD
Fluoxymesterone—Nausea—Lovastatin—atherosclerosis	0.000469	0.0107	CcSEcCtD
Fluoxymesterone—Headache—Simvastatin—atherosclerosis	0.000462	0.0106	CcSEcCtD
Fluoxymesterone—Nausea—Ezetimibe—atherosclerosis	0.00046	0.0105	CcSEcCtD
Fluoxymesterone—Nausea—Simvastatin—atherosclerosis	0.000438	0.01	CcSEcCtD
Fluoxymesterone—Danazol—ESR1—atherosclerosis	0.000431	0.0769	CrCbGaD
Fluoxymesterone—Headache—Niacin—atherosclerosis	0.000425	0.00969	CcSEcCtD
Fluoxymesterone—Headache—Pravastatin—atherosclerosis	0.000418	0.00954	CcSEcCtD
Fluoxymesterone—Nausea—Niacin—atherosclerosis	0.000403	0.00919	CcSEcCtD
Fluoxymesterone—Nausea—Pravastatin—atherosclerosis	0.000396	0.00905	CcSEcCtD
Fluoxymesterone—Medroxyprogesterone Acetate—ESR1—atherosclerosis	0.000387	0.0691	CrCbGaD
Fluoxymesterone—Dexamethasone—NOS2—atherosclerosis	0.000356	0.0635	CrCbGaD
Fluoxymesterone—Progesterone—ESR1—atherosclerosis	0.000224	0.0399	CrCbGaD
Fluoxymesterone—Triamcinolone—PTGS2—atherosclerosis	0.000215	0.0383	CrCbGaD
Fluoxymesterone—Betamethasone—PTGS2—atherosclerosis	0.000176	0.0313	CrCbGaD
Fluoxymesterone—Norethindrone—ALB—atherosclerosis	0.000171	0.0305	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000167	0.00108	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL6—atherosclerosis	0.000167	0.00108	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000167	0.00107	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD36—atherosclerosis	0.000166	0.00107	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000165	0.00106	CbGpPWpGaD
Fluoxymesterone—Methyltestosterone—ALB—atherosclerosis	0.000162	0.0289	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCR2—atherosclerosis	0.000161	0.00104	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EDNRA—atherosclerosis	0.000161	0.00104	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—PPARA—atherosclerosis	0.000161	0.00104	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	0.00016	0.00103	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CYBA—atherosclerosis	0.00016	0.00103	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.000158	0.00102	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PLAT—atherosclerosis	0.000157	0.00101	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PARP1—atherosclerosis	0.000157	0.00101	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GHRL—atherosclerosis	0.000157	0.00101	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—AGT—atherosclerosis	0.000156	0.00101	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—NFKB1—atherosclerosis	0.000155	0.000999	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—IL1B—atherosclerosis	0.000153	0.00099	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000153	0.000986	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—LEP—atherosclerosis	0.000153	0.000985	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PDGFB—atherosclerosis	0.000153	0.000984	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000151	0.000971	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CRP—atherosclerosis	0.000149	0.000962	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—MAPK3—atherosclerosis	0.000149	0.000961	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.000147	0.000946	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—STAT3—atherosclerosis	0.000146	0.000939	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000145	0.000932	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—NFKB1—atherosclerosis	0.000143	0.000923	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PDGFB—atherosclerosis	0.000143	0.000923	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—TLR4—atherosclerosis	0.000143	0.000922	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MMP1—atherosclerosis	0.000142	0.000917	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000141	0.000911	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—MAPK8—atherosclerosis	0.000141	0.000908	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KNG1—atherosclerosis	0.000138	0.000888	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ICAM1—atherosclerosis	0.000137	0.000884	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AGTR1—atherosclerosis	0.000137	0.000883	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—AKT1—atherosclerosis	0.000134	0.000867	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PLG—atherosclerosis	0.000133	0.00086	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—PPARG—atherosclerosis	0.000133	0.000858	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MAPK3—atherosclerosis	0.000133	0.000857	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.000131	0.000847	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—INS—atherosclerosis	0.00013	0.000841	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.000129	0.000832	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—TGFB1—atherosclerosis	0.000129	0.000832	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000129	0.000831	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—STAT3—atherosclerosis	0.000129	0.00083	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	0.000127	0.000819	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—AKT1—atherosclerosis	0.000127	0.000819	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SOCS3—atherosclerosis	0.000126	0.000815	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IGF1—atherosclerosis	0.000126	0.000814	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.000126	0.000813	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	0.000125	0.000807	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	0.000124	0.000801	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—MAPK3—atherosclerosis	0.000123	0.000793	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000122	0.000789	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PARP1—atherosclerosis	0.000122	0.000788	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP3—atherosclerosis	0.000122	0.000787	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF2—atherosclerosis	0.000121	0.000784	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	0.00012	0.000773	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOB—atherosclerosis	0.000118	0.000761	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EDN1—atherosclerosis	0.000116	0.000749	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR2—atherosclerosis	0.000116	0.000746	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	0.000116	0.000746	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL5—atherosclerosis	0.000115	0.000743	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	0.000113	0.000727	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—LPL—atherosclerosis	0.000113	0.000726	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL1B—atherosclerosis	0.000111	0.000715	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PRKCG—atherosclerosis	0.000109	0.000706	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—atherosclerosis	0.000109	0.000702	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SPP1—atherosclerosis	0.000107	0.000688	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	0.000106	0.000685	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IFNG—atherosclerosis	0.000104	0.000673	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	0.000103	0.000667	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PTGS2—atherosclerosis	0.000102	0.0182	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000101	0.000654	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	0.000101	0.000653	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PDGFB—atherosclerosis	9.87e-05	0.000636	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	9.64e-05	0.000622	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AGT—atherosclerosis	9.63e-05	0.000621	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—atherosclerosis	9.5e-05	0.000613	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—LEP—atherosclerosis	9.44e-05	0.000609	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOE—atherosclerosis	9.44e-05	0.000609	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	9.42e-05	0.000607	CbGpPWpGaD
Fluoxymesterone—Testosterone—ALB—atherosclerosis	9.41e-05	0.0168	CrCbGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PARP1—atherosclerosis	9.41e-05	0.000607	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	9.39e-05	0.000606	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—atherosclerosis	9.39e-05	0.000605	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	9.35e-05	0.000603	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CAV1—atherosclerosis	9.35e-05	0.000603	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOA1—atherosclerosis	9.33e-05	0.000602	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL1B—atherosclerosis	9.31e-05	0.0006	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	9.27e-05	0.000598	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ESR1—atherosclerosis	9.01e-05	0.000581	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—atherosclerosis	8.97e-05	0.000578	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—ESR2—atherosclerosis	8.91e-05	0.000575	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—F2—atherosclerosis	8.9e-05	0.000574	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	8.8e-05	0.000567	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	8.78e-05	0.000566	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	8.77e-05	0.000566	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—NFKB1—atherosclerosis	8.68e-05	0.00056	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	8.65e-05	0.000558	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK8—atherosclerosis	8.53e-05	0.00055	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PIK3CG—atherosclerosis	8.52e-05	0.000549	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	8.41e-05	0.000543	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—atherosclerosis	8.29e-05	0.000535	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	8.24e-05	0.000532	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	8.18e-05	0.000528	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—STAT3—atherosclerosis	8.16e-05	0.000526	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—INS—atherosclerosis	8.06e-05	0.00052	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—atherosclerosis	8.05e-05	0.000519	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	7.99e-05	0.000515	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CCL2—atherosclerosis	7.93e-05	0.000512	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	7.85e-05	0.000506	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	7.81e-05	0.000504	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—STAT3—atherosclerosis	7.8e-05	0.000503	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1—atherosclerosis	7.8e-05	0.000503	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	7.8e-05	0.000503	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARA—atherosclerosis	7.75e-05	0.0005	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	7.68e-05	0.000495	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	7.6e-05	0.00049	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TGFB1—atherosclerosis	7.57e-05	0.000488	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	7.55e-05	0.000487	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK3—atherosclerosis	7.45e-05	0.000481	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	7.42e-05	0.000479	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SERPINE1—atherosclerosis	7.41e-05	0.000478	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	7.33e-05	0.000473	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	7.12e-05	0.000459	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOS3—atherosclerosis	7.07e-05	0.000456	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—atherosclerosis	7.06e-05	0.000456	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—ESR1—atherosclerosis	7.02e-05	0.000453	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MAPK3—atherosclerosis	6.99e-05	0.000451	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	6.84e-05	0.000441	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	6.78e-05	0.000437	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HRH1—atherosclerosis	6.77e-05	0.000437	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	6.66e-05	0.00043	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HSPA1B—atherosclerosis	6.6e-05	0.000426	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—atherosclerosis	6.49e-05	0.000419	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PPARG—atherosclerosis	6.4e-05	0.000413	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL8—atherosclerosis	6.27e-05	0.000405	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	6.15e-05	0.000397	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	6.15e-05	0.000397	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	6.11e-05	0.000394	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARA—atherosclerosis	5.97e-05	0.000385	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PARP1—atherosclerosis	5.88e-05	0.000379	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	5.88e-05	0.000379	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	5.82e-05	0.000375	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—SERPINE1—atherosclerosis	5.77e-05	0.000372	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—atherosclerosis	5.7e-05	0.000368	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—atherosclerosis	5.67e-05	0.000366	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	5.65e-05	0.000364	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NFKB1—atherosclerosis	5.61e-05	0.000362	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR2—atherosclerosis	5.57e-05	0.000359	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK8—atherosclerosis	5.52e-05	0.000356	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—atherosclerosis	5.45e-05	0.000351	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	5.32e-05	0.000343	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOA4—atherosclerosis	5.31e-05	0.000343	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	5.27e-05	0.00034	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—atherosclerosis	5.11e-05	0.000329	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	5.1e-05	0.000329	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—atherosclerosis	5.09e-05	0.000329	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HSPA1B—atherosclerosis	5.08e-05	0.000328	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—atherosclerosis	5.04e-05	0.000325	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—atherosclerosis	5.03e-05	0.000324	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HSPA1B—atherosclerosis	5.01e-05	0.000323	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PPARG—atherosclerosis	4.93e-05	0.000318	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	4.93e-05	0.000318	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL4—atherosclerosis	4.89e-05	0.000316	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	4.86e-05	0.000313	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK3—atherosclerosis	4.82e-05	0.000311	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	4.74e-05	0.000306	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—atherosclerosis	4.71e-05	0.000304	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—atherosclerosis	4.68e-05	0.000302	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOA2—atherosclerosis	4.57e-05	0.000295	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PARP1—atherosclerosis	4.53e-05	0.000292	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SIRT1—atherosclerosis	4.49e-05	0.000289	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PARP1—atherosclerosis	4.46e-05	0.000288	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—SERPINE1—atherosclerosis	4.44e-05	0.000287	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	4.38e-05	0.000282	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—UTS2—atherosclerosis	4.36e-05	0.000281	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—ESR2—atherosclerosis	4.29e-05	0.000277	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR2—atherosclerosis	4.23e-05	0.000273	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CX3CR1—atherosclerosis	4.18e-05	0.00027	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASR—atherosclerosis	4.18e-05	0.00027	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CX3CL1—atherosclerosis	4.1e-05	0.000264	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	3.93e-05	0.000253	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CNR2—atherosclerosis	3.89e-05	0.000251	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARA—atherosclerosis	3.73e-05	0.000241	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—atherosclerosis	3.52e-05	0.000227	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VWF—atherosclerosis	3.47e-05	0.000223	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SIRT1—atherosclerosis	3.46e-05	0.000223	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOC3—atherosclerosis	3.44e-05	0.000222	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LDLR—atherosclerosis	3.42e-05	0.000221	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SIRT1—atherosclerosis	3.4e-05	0.00022	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—ESR1—atherosclerosis	3.38e-05	0.000218	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL3—atherosclerosis	3.34e-05	0.000216	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—atherosclerosis	3.25e-05	0.00021	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NCF1—atherosclerosis	3.2e-05	0.000206	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PPARG—atherosclerosis	3.08e-05	0.000199	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCR2—atherosclerosis	3.02e-05	0.000195	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EDNRA—atherosclerosis	3.02e-05	0.000195	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CYBA—atherosclerosis	3.01e-05	0.000194	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PLAT—atherosclerosis	2.95e-05	0.00019	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GHRL—atherosclerosis	2.95e-05	0.00019	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PARP1—atherosclerosis	2.95e-05	0.00019	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARA—atherosclerosis	2.87e-05	0.000185	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARA—atherosclerosis	2.83e-05	0.000182	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SERPINE1—atherosclerosis	2.78e-05	0.000179	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KNG1—atherosclerosis	2.59e-05	0.000167	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AGTR1—atherosclerosis	2.57e-05	0.000166	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—ESR1—atherosclerosis	2.56e-05	0.000165	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PLG—atherosclerosis	2.51e-05	0.000162	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PPARG—atherosclerosis	2.37e-05	0.000153	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SOCS3—atherosclerosis	2.37e-05	0.000153	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PPARG—atherosclerosis	2.34e-05	0.000151	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP3—atherosclerosis	2.29e-05	0.000148	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF2—atherosclerosis	2.28e-05	0.000147	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOB—atherosclerosis	2.21e-05	0.000143	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EDN1—atherosclerosis	2.18e-05	0.000141	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL5—atherosclerosis	2.16e-05	0.000139	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SERPINE1—atherosclerosis	2.14e-05	0.000138	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LPL—atherosclerosis	2.11e-05	0.000136	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SERPINE1—atherosclerosis	2.11e-05	0.000136	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PRKCG—atherosclerosis	2.06e-05	0.000133	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SPP1—atherosclerosis	2e-05	0.000129	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDGFB—atherosclerosis	1.85e-05	0.00012	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AGT—atherosclerosis	1.81e-05	0.000117	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—MAPK3—atherosclerosis	1.81e-05	0.000117	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LEP—atherosclerosis	1.77e-05	0.000114	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOE—atherosclerosis	1.77e-05	0.000114	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CAV1—atherosclerosis	1.76e-05	0.000113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOA1—atherosclerosis	1.75e-05	0.000113	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—F2—atherosclerosis	1.67e-05	0.000108	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PIK3CG—atherosclerosis	1.6e-05	0.000103	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—INS—atherosclerosis	1.51e-05	9.77e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CCL2—atherosclerosis	1.49e-05	9.61e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1—atherosclerosis	1.46e-05	9.45e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—MAPK3—atherosclerosis	1.39e-05	8.98e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SERPINE1—atherosclerosis	1.39e-05	8.97e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—MAPK3—atherosclerosis	1.37e-05	8.84e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOS3—atherosclerosis	1.33e-05	8.56e-05	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—atherosclerosis	1.22e-05	7.86e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL8—atherosclerosis	1.18e-05	7.6e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—atherosclerosis	1.07e-05	6.87e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NFKB1—atherosclerosis	1.05e-05	6.8e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK8—atherosclerosis	1.04e-05	6.68e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—atherosclerosis	9.57e-06	6.17e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—atherosclerosis	9.47e-06	6.11e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—atherosclerosis	9.39e-06	6.05e-05	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—atherosclerosis	9.25e-06	5.96e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK3—atherosclerosis	9.05e-06	5.84e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—atherosclerosis	8.78e-06	5.66e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—atherosclerosis	6.62e-06	4.27e-05	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—atherosclerosis	6.1e-06	3.94e-05	CbGpPWpGaD
